280 related articles for article (PubMed ID: 7999818)
1. Staphylococcus aureus CAPD-related infections are associated with nasal carriage.
Lye WC; Leong SO; van der Straaten J; Lee EJ
Adv Perit Dial; 1994; 10():163-5. PubMed ID: 7999818
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcus aureus nasal carriage and infection in patients on continuous ambulatory peritoneal dialysis.
Luzar MA; Coles GA; Faller B; Slingeneyer A; Dah GD; Briat C; Wone C; Knefati Y; Kessler M; Peluso F
N Engl J Med; 1990 Feb; 322(8):505-9. PubMed ID: 2300122
[TBL] [Abstract][Full Text] [Related]
3. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.
Hanslik TM; Newman L; Tessman M; Morrissey AB; Friedlander MA
Adv Perit Dial; 1994; 10():158-62. PubMed ID: 7999817
[TBL] [Abstract][Full Text] [Related]
4. Staphylococcus aureus skin carriage and development of peritonitis in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Draibe S; Castelo A; Sato I; Leme I; Barbosa D; Ramos O
Clin Nephrol; 1989 May; 31(5):264-8. PubMed ID: 2736815
[TBL] [Abstract][Full Text] [Related]
5. Carrier-status for nasal staphylococci does not predict infections in CAPD patients.
Lubrich-Birkner I; Schollmeyer P; Böhler J
Adv Perit Dial; 1994; 10():154-7. PubMed ID: 7999816
[TBL] [Abstract][Full Text] [Related]
6. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
[TBL] [Abstract][Full Text] [Related]
7. Prevention of staphylococcal peritonitis in CAPD patients combining ablution and mupirocin.
Al-Hwiesh AK; Abdul Rahman IS
Saudi J Kidney Dis Transpl; 2008 Sep; 19(5):737-45. PubMed ID: 18711288
[TBL] [Abstract][Full Text] [Related]
8. The effects of once- or thrice-weekly mupirocin application on mupirocin resistance in patients on continuous ambulatory peritoneal dialysis--first 6 months' experience.
Cavdar C; Zeybel M; Atay T; Sifil A; Sanlidag C; Gulay Z; Camsari T
Adv Perit Dial; 2004; 20():62-6. PubMed ID: 15384797
[TBL] [Abstract][Full Text] [Related]
9. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
[TBL] [Abstract][Full Text] [Related]
10. Effect of sodium fusidate and ofloxacin on Staphylococcus aureus colonization and infection in patients on continuous ambulatory peritoneal dialysis.
Sesso R; Parisio K; Dalboni A; Rabelo T; Barbosa D; Cendoroglo M; Pignatari A; Draibe S; Ajzen H
Clin Nephrol; 1994 Jun; 41(6):370-6. PubMed ID: 8076441
[TBL] [Abstract][Full Text] [Related]
11. An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD).
Bernardini J; Holley JL; Johnston JR; Perlmutter JA; Piraino B
Clin Nephrol; 1991 Jul; 36(1):29-34. PubMed ID: 1889148
[TBL] [Abstract][Full Text] [Related]
12. Staphylococcus aureus nasal carriage in children receiving long-term peritoneal dialysis.
Kingwatanakul P; Warady BA
Adv Perit Dial; 1997; 13():281-4. PubMed ID: 9360700
[TBL] [Abstract][Full Text] [Related]
13. Staphylococcus aureus nasal carrier status (SANCS) in CAPD patients; is it induced or favored by subcutaneous rHu-erythropoietin?
Selgas R; Castro MJ; Bajo MA; Fernandez-Reyes MJ; Lopez-Revuelta K; Romero JR; de Alvaro F; Borrego F; Riñon C
Adv Perit Dial; 1992; 8():253-7. PubMed ID: 1361800
[TBL] [Abstract][Full Text] [Related]
14. A prospective study of peritoneal dialysis-related infections in CAPD patients with diabetes mellitus.
Lye WC; Leong SO; van der Straaten JC; Lee EJ
Adv Perit Dial; 1993; 9():195-7. PubMed ID: 8105922
[TBL] [Abstract][Full Text] [Related]
15. Association of Staphylococcus nasal colonization and HIV in end-stage renal failure patients undergoing peritoneal dialysis.
Ndlovu KCZ; Swe Swe-Han K; Assounga A
Ren Fail; 2019 Nov; 41(1):303-313. PubMed ID: 30991864
[TBL] [Abstract][Full Text] [Related]
16. Does catheter immobilization reduce exit-site infections in CAPD patients?
Turner K; Edgar D; Hair M; Uttley L; Sternland R; Hunt L; Gokal R
Adv Perit Dial; 1992; 8():265-8. PubMed ID: 1361803
[TBL] [Abstract][Full Text] [Related]
17. Vaccination for prevention of CAPD associated staphylococcal infection: results of a prospective multicentre clinical trial.
Poole-Warren LA; Hallett MD; Hone PW; Burden SH; Farrell PC
Clin Nephrol; 1991 May; 35(5):198-206. PubMed ID: 1855327
[TBL] [Abstract][Full Text] [Related]
18. The treatment of Staphylococcus aureus nasal carriage in pediatric peritoneal dialysis patients.
Blowey DL; Warady BA; McFarland KS
Adv Perit Dial; 1994; 10():297-9. PubMed ID: 7999849
[TBL] [Abstract][Full Text] [Related]
19. Breaking-in after the insertion of Tenckhoff catheters: a comparison of two techniques.
Lye WC; Giang MM; van der Straaten JC; Lee EJ
Adv Perit Dial; 1993; 9():236-9. PubMed ID: 8105933
[TBL] [Abstract][Full Text] [Related]
20. Does the response to hepatitis B vaccination predict CAPD-associated infections?
Holley JL
Adv Perit Dial; 1996; 12():218-20. PubMed ID: 8865907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
